Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (27 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Dec 2021 – 20 Aug 2026, limited by Quant Value Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Quant Value Fund | Nifty 500 |
|---|---|---|
| 01 Dec 2021 | ₹100.00 | ₹100.00 |
| 24 Apr 2022 | ₹104.26 | ₹100.75 |
| 14 Sep 2022 | ₹107.43 | ₹105.72 |
| 05 Feb 2023 | ₹106.79 | ₹101.20 |
| 28 Jun 2023 | ₹117.79 | ₹110.09 |
| 19 Nov 2023 | ₹135.69 | ₹119.05 |
| 11 Apr 2024 | ₹193.51 | ₹141.47 |
| 01 Sep 2024 | ₹217.08 | ₹160.53 |
| 23 Jan 2025 | ₹188.01 | ₹145.68 |
| 15 Jun 2025 | ₹192.81 | ₹154.93 |
| 06 Nov 2025 | ₹197.86 | ₹159.04 |
| 29 Mar 2026 | ₹185.55 | ₹142.18 |
| 20 Aug 2026 | ₹227.21 | ₹159.04 |
| Metric | quant · Direct · IDCW NAV ₹22.82 Very High risk ★★★★★ | Category median Value Fund · 27 funds |
|---|---|---|
| +17.06% | +2.79% | |
| +22.07% | +12.68% | |
| — | +11.98% | |
| — | +10.69% | |
| +19.00% | +11.75% | |
| +19.68% | — | |
| +23.90% | +13.57% | |
| — | +12.46% | |
| — | +12.08% | |
| Risk | ||
| 18.80% | 14.87% | |
| 0.83 | 0.40 | |
| 1.13 | 0.54 | |
| -24.03% | -37.93% | |
| Nifty 500 | — | |
| +8.67% | +0.85% | |
| 1.22 | 0.95 | |
| 137.2% | 102.9% | |
| 103.2% | 102.9% | |
| 0.92% | 1.20% | |
| ₹1,784Cr | ₹1,405Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 40% | |
| Sanjeev Sharma | — | |
| 01 Dec 2021 | — | |
| 24 | — | |
| 61.1% | — | |
| 9.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.